Brain Advance Access published online on June 4, 2003
Brain, doi:10.1093/brain/awg178
© 2003 by Guarantors of Brain
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
1 Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
* Corresponding author. E-mail: vyong{at}ucalgary.ca.
Received 14 March 2003
; accepted 17 March 2003
Acute spinal cord injury (SCI) produces tissue damage that continues to evolve days and weeks after the initial insult, with corresponding functional impairments. Reducing the extent of progressive tissue loss (‘neuroprotection') following SCI should result in a better recovery from SCI, but treatment options have thus far been limited. In this study, we have tested the efficacy of minocycline in ameliorating damage following acute SCI in mice. This semi-synthetic tetracycline antibiotic has been reported to inhibit the expression and activity of several mediators of tissue injury, including inflammatory cytokines, free radicals and matrix metalloproteinases, making it a suitable candidate for study. Mice were subjected to extradural compression of the spinal cord using a modified aneurysm clip, following which they received treatment with either minocycline or vehicle beginning 1 h after injury. Behavioural testing of hindlimb function was initiated 3 days after injury using the Basso Beattie Bresnahan locomotor rating scale, and at 1 week using the inclined plane test. Functional assessments demonstrated that minocycline administration significantly improved both hindlimb function and strength from 3 to 28 days after injury compared with vehicle controls. Furthermore, gross lesion size in the spinal cord was significantly reduced by minocycline, and there was evidence of axonal sparing as determined using fluorogold labelling of the rubrospinal tract and by Bielchowsky silver stain. Finally, a comparison of minocycline against the currently approved treatment for acute SCI in humans, methylprednisolone, demonstrated superior behavioural recovery in the minocycline-treated animals.
Keywords: inflammation; minocycline; neuroprotection; recovery; spinal cord injury
Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice
2 Department of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Peng, M. L. Cotrina, X. Han, H. Yu, L. Bekar, L. Blum, T. Takano, G.-F. Tian, S. A. Goldman, and M. Nedergaard From the Cover: Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury PNAS, July 28, 2009; 106(30): 12489 - 12493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Murata, A. Rosell, R. H. Scannevin, K. J. Rhodes, X. Wang, and E. H. Lo Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke Stroke, December 1, 2008; 39(12): 3372 - 3377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kielian, N. Esen, S. Liu, N. K. Phulwani, M. M. Syed, N. Phillips, K. Nishina, A. L. Cheung, J. D. Schwartzman, and J. J. Ruhe Minocycline Modulates Neuroinflammation Independently of Its Antimicrobial Activity in Staphylococcus aureus-Induced Brain Abscess Am. J. Pathol., October 1, 2007; 171(4): 1199 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Yune, J. Y. Lee, G. Y. Jung, S. J. Kim, M. H. Jiang, Y. C. Kim, Y. J. Oh, G. J. Markelonis, and T. H. Oh Minocycline Alleviates Death of Oligodendrocytes by Inhibiting Pro-Nerve Growth Factor Production in Microglia after Spinal Cord Injury J. Neurosci., July 18, 2007; 27(29): 7751 - 7761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Birnbaum, T. P. Leist, and F. D. Lublin Commentary I: Pathophysiologic construct for neuronal degeneration/regeneration in multiple sclerosis Neurology, May 29, 2007; 68(22_suppl_3): S2 - S4. [Full Text] [PDF]
|
|
|
|
|
|
V. W. Yong, F. Giuliani, M. Xue, A. Bar-Or, and L. M. Metz Experimental models of neuroprotection relevant to multiple sclerosis Neurology, May 29, 2007; 68(22_suppl_3): S32 - S37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhou, B. M. Lapointe, S. R. Clark, L. Zbytnuik, and P. Kubes A Requirement for Microglial TLR4 in Leukocyte Recruitment into Brain in Response to Lipopolysaccharide J. Immunol., December 1, 2006; 177(11): 8103 - 8110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Qiao, C. Atkinson, H. Song, R. Pannu, I. Singh, and S. Tomlinson Complement Plays an Important Role in Spinal Cord Injury and Represents a Therapeutic Target for Improving Recovery following Trauma Am. J. Pathol., September 1, 2006; 169(3): 1039 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Hains and S. G. Waxman Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., April 19, 2006; 26(16): 4308 - 4317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. X. Jiang, J. Lertvorachon, S. T. Hou, Y. Konishi, J. Webster, G. Mealing, E. Brunette, J. Tauskela, and E. Preston Chlortetracycline and Demeclocycline Inhibit Calpains and Protect Mouse Neurons against Glutamate Toxicity and Cerebral Ischemia J. Biol. Chem., October 7, 2005; 280(40): 33811 - 33818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Stirling, K. M. Koochesfahani, J. D. Steeves, and W. Tetzlaff Minocycline as a Neuroprotective Agent Neuroscientist, August 1, 2005; 11(4): 308 - 322. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Giuliani, W. Hader, and V. W. Yong Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction J. Leukoc. Biol., July 1, 2005; 78(1): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, B. Lei, T. T. Lam, F. Yang, D. Sinha, and M. O. M. Tso Neuroprotection of Photoreceptors by Minocycline in Light-Induced Retinal Degeneration Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2753 - 2759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. Stavrovskaya, M. V. Narayanan, W. Zhang, B. F. Krasnikov, J. Heemskerk, S. S. Young, J. P. Blass, A. M. Brown, M. F. Beal, R. M. Friedlander, et al. Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology J. Exp. Med., July 19, 2004; 200(2): 211 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gris, D. R. Marsh, M. A. Oatway, Y. Chen, E. F. Hamilton, G. A. Dekaban, and L. C. Weaver Transient Blockade of the CD11d/CD18 Integrin Reduces Secondary Damage after Spinal Cord Injury, Improving Sensory, Autonomic, and Motor Function J. Neurosci., April 21, 2004; 24(16): 4043 - 4051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Stirling, K. Khodarahmi, J. Liu, L. T. McPhail, C. B. McBride, J. D. Steeves, M. S. Ramer, and W. Tetzlaff Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury J. Neurosci., March 3, 2004; 24(9): 2182 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Teng, H. Choi, R. C. Onario, S. Zhu, F. C. Desilets, S. Lan, E. J. Woodard, E. Y. Snyder, M. E. Eichler, and R. M. Friedlander Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury PNAS, March 2, 2004; 101(9): 3071 - 3076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. A. Wells, T. K. Rice, R. K. Nuttall, D. R. Edwards, H. Zekki, S. Rivest, and V. W. Yong An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice J. Neurosci., November 5, 2003; 23(31): 10107 - 10115. [Abstract] [Full Text] [PDF]
|
|